Trial Profile
The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorder With Psychotic Symptoms.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Postnatal depression
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Oct 2008 Status changed from recruiting to discontinued according to ClinicalTrials.gov record.
- 10 Jun 2008 New trial record.